The structure and function of the glucagon-like peptide-1 receptor and its ligands

被引:211
作者
Donnelly, Dan [1 ]
机构
[1] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England
关键词
GLP-1; GPCR; exendin-4; exenatide; liraglutide; diabetes; glucagon; insulin; VASOACTIVE-INTESTINAL-PEPTIDE; GUINEA-PIG PANCREAS; N-TERMINAL DOMAIN; GLP-1; 7-36; AMIDE; IN-VITRO; INSULIN-SECRETION; DISPERSED ACINI; EXTRACELLULAR DOMAIN; PARATHYROID-HORMONE; BIOLOGICAL-ACTIVITY;
D O I
10.1111/j.1476-5381.2011.01687.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-residue peptide hormone released from intestinal L cells following nutrient consumption. It potentiates the glucose-induced secretion of insulin from pancreatic beta cells, increases insulin expression, inhibits beta-cell apoptosis, promotes beta-cell neogenesis, reduces glucagon secretion, delays gastric emptying, promotes satiety and increases peripheral glucose disposal. These multiple effects have generated a great deal of interest in the discovery of long-lasting agonists of the GLP-1 receptor (GLP-1R) in order to treat type 2 diabetes. This review article summarizes the literature regarding the discovery of GLP-1 and its physiological functions. The structure, function and sequenceactivity relationships of the hormone and its natural analogue exendin-4 (Ex4) are reviewed in detail. The current knowledge of the structure of GLP-1R, a Family B GPCR, is summarized and discussed, before its known interactions with the principle peptide ligands are described and summarized. Finally, progress in discovering non-peptide ligands of GLP-1R is reviewed. GLP-1 is clearly an important hormone linking nutrient consumption with blood sugar control, and therefore knowledge of its structure, function and mechanism of action is of great importance.
引用
收藏
页码:27 / 41
页数:15
相关论文
共 140 条
  • [1] ADELHORST K, 1994, J BIOL CHEM, V269, P6275
  • [2] GLP-1 for type 2 diabetes
    Ahren, Bo
    [J]. EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1239 - 1245
  • [3] The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists
    Al-Sabah, S
    Donnelly, D
    [J]. PROTEIN AND PEPTIDE LETTERS, 2004, 11 (01) : 9 - 14
  • [4] The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists
    Al-Sabah, S
    Donnelly, D
    [J]. FEBS LETTERS, 2003, 553 (03) : 342 - 346
  • [5] A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors
    Al-Sabah, S
    Donnelly, D
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) : 339 - 346
  • [6] Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1
    Andersen, NH
    Brodsky, Y
    Neidigh, JW
    Prickett, KS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (01) : 79 - 85
  • [7] Synthesis and antidiabetic activity of 3,6,7-trisubstituted-2-(1H-imidazol-2-ylsulfanyl)quinoxalines and quinoxalin-2-yl isothioureas
    Bahekar, Rajesh H.
    Jain, Mukul R.
    Gupta, Arun A.
    Goel, Ashish
    Jadav, Pradip A.
    Patel, Dipam N.
    Prajapati, Vijay M.
    Patel, Pankaj R.
    [J]. ARCHIV DER PHARMAZIE, 2007, 340 (07) : 359 - 366
  • [8] THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS
    BALDWIN, JM
    [J]. EMBO JOURNAL, 1993, 12 (04) : 1693 - 1703
  • [9] In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor
    Bazarsuren, A
    Grauschopf, U
    Wozny, M
    Reusch, D
    Hoffmann, E
    Schaefer, W
    Panzner, S
    Rudolph, R
    [J]. BIOPHYSICAL CHEMISTRY, 2002, 96 (2-3) : 305 - 318
  • [10] A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness
    Beinborn, M
    Worrall, CI
    McBride, EW
    Kopin, AS
    [J]. REGULATORY PEPTIDES, 2005, 130 (1-2) : 1 - 6